- Home
- SGD vs ADVB Comparison
SGD vs ADVB Comparison
Compare SGD & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGD | ADVB |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.4M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SGD | ADVB |
|---|---|---|
| Price | $0.33 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 1.3M |
| Earning Date | 11-14-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,970,752.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2770.15 | N/A |
| 52 Week Low | $0.17 | $0.31 |
| 52 Week High | $3.03 | $4.10 |
Technical Indicators
Market Signals| Indicator | SGD | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 29.48 | 36.50 |
| Support Level | $0.17 | $0.31 |
| Resistance Level | $0.30 | $0.40 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 11.37 | 24.71 |
Price Performance
Historical ComparisonAbout SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.
About ADVB Advanced Biomed Inc.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.